Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T19:32:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:07:48.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-29T05:56:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page has updated its event dates and removed references to the Nebraska Medicine Heartland Hematology Oncology, while adding information about the Fred and Pamela Buffett Cancer Center in Kearney.
    Difference
    0.4%
    Check dated 2025-05-14T20:45:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page has updated the name of the medical center to 'MaineHealth Maine Medical Center- Scarborough' and has revised the version number to v2.15.2. Additionally, several older dates and the previous version number v2.15.0 have been removed.
    Difference
    0.3%
    Check dated 2025-04-30T13:52:32.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers and collaborators related to clinical trials for recurrent ovarian and fallopian tube cancers, while significant details about the trial's objectives and treatment protocols have been removed.
    Difference
    40%
    Check dated 2025-04-16T01:50:43.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.